Quantcast

Latest Lilly Stories

2014-04-09 08:28:42

Research Projects Will Use Real-World Evidence to Support People Living With Type 1 Diabetes BOSTON and INDIANAPOLIS, April 9, 2014 /PRNewswire/ -- T1D Exchange and Eli Lilly and Company (NYSE: LLY) announced today they have entered into a research collaboration that will enable both organizations to gain deeper, real-world insight about the experience of people with type 1 diabetes, to identify new ways to improve care and advance outcomes. As part of this multi-year...

2014-04-08 08:32:57

INDIANAPOLIS, April 8, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) issued the following statement today in response to the verdict in the case of Terrence Allen, et al. v. Takeda Pharmaceuticals North America, Inc., et al. No. 6:12-cv-00064. The jury found in favor of the plaintiffs and awarded $1.475 million in compensatory damages. The allocation of liability was 75% Takeda and 25% Lilly. The jury also awarded $6 billion in punitive damages from Takeda and $3 billion from...

2014-04-06 12:20:19

INDIANAPOLIS, April 6, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will present early-stage data from several targeted cancer therapies - including bemaciclib "beh meh sye' klib" (LY2835219), its oral, cell-cycle inhibitor of CDK4/6 - that make up its diverse clinical oncology pipeline during the American Association for Cancer Research (AACR) Annual Meeting 2014 held in San Diego, Calif. from April 5 - 9. "Harnessing Breakthroughs - Targeting Cures" is the theme of this year's...

2014-03-31 20:22:46

INDIANAPOLIS, March 31, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. District Court for the Southern District of Indiana has ruled in the company's favor regarding the vitamin dosage regimen patent for Alimta(®) (pemetrexed for injection). In the case of Eli Lilly and Company v. Teva Parenteral Medicines Inc., et al., the court ruled the vitamin dosage regimen patent is valid and enforceable. The patent provides intellectual property protection...

2014-03-26 08:26:19

Revlon Global Brand Ambassadors Halle Berry & Emma Stone, along with Christina Applegate to Host 2014 Events in New York City on May 3rd & Los Angeles on May 10th LOS ANGELES, March 26, 2014 /PRNewswire-USNewswire/ -- Revlon (NYSE: REV), The Entertainment Industry Foundation (EIF) and Lilly Tartikoff are proud to announce the 21(st) annual EIF Revlon Run/Walk for Women. Revlon Brand Ambassador Emma Stone will host the 2014 event in New York on Saturday, May 3(rd )and Revlon Brand...

2014-03-05 16:26:36

INDIANAPOLIS, March 5, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will attend the Barclays Global Healthcare Conference on Wednesday, March 12, 2014. David Ricks, Lilly senior vice president, and president of Lilly Bio-Medicines, will participate in a fireside chat at 1:00 p.m. EDT. A live audio webcast will be available on the Webcasts & Presentations section of Lilly's Investor website at http://investor.lilly.com/events.cfm. Subsequently, a replay of the fireside...

2014-03-05 12:26:22

Boehringer Ingelheim and Lilly are committed to working with the FDA RIDGEFIELD, Conn. and INDIANAPOLIS, March 5, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly and Company (Lilly; NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) has issued a complete response letter for the New Drug Application (NDA) of the investigational sodium glucose co-transporter-2 (SGLT2) inhibitor empagliflozin. The complete response letter...

2014-02-24 08:28:13

Deal Provides Elanco with a Leading Poultry Vaccine Portfolio and Manufacturing Capabilities GREENFIELD, IN, Feb. 24, 2014 /PRNewswire/ -- Elanco, the animal health division of Eli Lilly and Company (NYSE:LLY), today announced an agreement to acquire Lohmann SE (Lohmann Animal Health), a privately-held company headquartered in Cuxhaven, Germany. Lohmann Animal Health is a global leader in the supply of poultry vaccines and also markets a range of feed additives. The acquisition will...

2014-02-21 12:24:54

INDIANAPOLIS, Feb. 21, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will attend the 34(th) Annual Cowen and Company Healthcare Conference on Tuesday, March 4, 2014. Derica Rice, Lilly executive vice president, global services, and chief financial officer, will participate in a fireside chat at 11:20 a.m. EST. A live audio webcast will be available on the Webcasts & Presentations section of Lilly's Investor website at http://investor.lilly.com/events.cfm. Subsequently, a...

2014-02-19 08:31:13

-- Ramucirumab Improved Survival in Second-Line Study of Patients with Non-Small Cell Lung Cancer -- INDIANAPOLIS, Feb. 19, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the REVEL trial, a global Phase III study of ramucirumab in combination with chemotherapy in patients with second-line non-small cell lung cancer (NSCLC), showed a statistically significant improvement in the primary endpoint of overall survival in the ramucirumab-plus-docetaxel arm...


Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related